Fayetteville, AR, United States of America

Nicholas R Gyles

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas R Gyles. Retrieved from https://idiyas.com/inventor/nicholas-r-gyles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicholas R Gyles

Introduction

Nicholas R Gyles is an accomplished inventor based in Fayetteville, AR (US). He has made significant contributions to the field of antiviral research, particularly through his innovative patent that addresses critical health challenges.

Latest Patents

One of Gyles' notable patents is focused on low molecular weight antiviral factors. This invention provides a method for isolating antiviral factors from the serum of a hyperimmune regressor line chicken. The factors identified in this patent are useful in the treatment and prevention of certain disease states, showcasing Gyles' commitment to advancing medical science.

Career Highlights

Throughout his career, Gyles has demonstrated a strong dedication to research and innovation. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications that could benefit public health.

Collaborations

Gyles has collaborated with esteemed colleagues such as Craig E Whitfill and John A Thoma. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.

Conclusion

Nicholas R Gyles is a notable inventor whose work in antiviral factors exemplifies the impact of innovation in healthcare. His contributions continue to inspire advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…